Categories: Stocks / ETFs

Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial

Recent Posts

Man wanted in Ottawa after allegedly removing woman’s hijab: police – Ottawa

Ottawa police say they’re searching for a man after a woman had her hijab removed…

2 hours ago

Midstream Energy ETFs Prove Resilient Amid Crude Oil Drop

The midstream energy segment is standing out for its resilience as oil prices face downward…

2 hours ago

Mourners gather to remember Lebanese conservationist killed by Israel | Israel attacks Lebanon News

Renowned turtle conservationist Mona Khalil had been wounded in an Israeli attack in southern Lebanon.Published…

3 hours ago

Ripple’s Chris Larsen on Secretive Thiel Dialog Network: Analysis & Privacy Questions

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure Public disclosures…

3 hours ago

More than 100mm of rain falls on Montreal: floods homes, causes outages – Montreal

Thousands of people in Montreal are without power, and some basements are inundated with water…

5 hours ago

The Muni Brief: Big Flows, Low Drama

Muni ETFs just posted record inflows. Jim Colby on why low volatility, strong risk-adjusted returns,…

7 hours ago